Baseline clinical features in the two groups of patients with DMR
Variables | With DMR(n=83) | Middle-aged group (40≤age≤59, n=34) | Elderly group (age≥60, n=49) | P-value | |||||
---|---|---|---|---|---|---|---|---|---|
Number | Weighted % (SE) | Number | Weighted % (SE) | Number | Weighted % (SE) | ||||
Co-morbidity | |||||||||
Hypertension | 43 | 43.7 (6.11) | 8 | 19.0 (8.23) | 35 | 71.7 (6.75) | <0.001 | ||
Hyperlipidemia | 34 | 40.2 (6.18) | 14 | 38.5 (8.36) | 20 | 42.1 (7.61) | 0.731 | ||
Cerebral Inf. | 7 | 7.3 (2.74) | 4 | 8.5 (4.28) | 3 | 5.8 (3.26) | 0.607 | ||
HbA1C, % | 83 | 7.7 (0.26) | 34 | 8.2 (0.39) | 49 | 7.3 (0.20) | 0.035 | ||
FBS, g/dl | 83 | 161.7 (8.38) | 34 | 177.6 (12.90) | 49 | 143.6 (5.51) | 0.011 | ||
BMI, kg/m2 | 83 | 24.8 (0.40) | 34 | 25.1 (0.54) | 49 | 24.5 (0.60) | 0.476 | ||
TG, mg/dL | 83 | 152.0 (14.43) | 34 | 162.4 (22.50) | 49 | 140.1 (10.10) | 0.286 | ||
LDL-C, mg/dL | 19 | 114.4 (16.15) | 10 | 100.9 (22.28) | 9 | 132.3 (11.24) | 0.240 | ||
HDL-C, mg/dL | 83 | 44.5 (1.44) | 34 | 45.2 (2.04) | 49 | 43.8 (1.84) | 0.606 | ||
DM treatment, yes | 69 | 80.8 (4.60) | 25 | 72.8 (7.75) | 44 | 89.8 (4.76) | 0.077 | ||
Insulin | 10 | 9.1 (2.79) | 3 | 6.1 (3.63) | 7 | 12.4 (4.75) | 0.324 | ||
OHA | 68 | 80.6 (4.60) | 25 | 72.8 (7.75) | 43 | 89.4 (4.77) | 0.082 | ||
Non-drug | 6 | 10.7 (4.71) | 4 | 16.4 (7.93) | 2 | 4.2 (2.93) | 0.058 |
DMR, diabetic retinopathy; HbA1C, glycated hemoglobin; FBS, fasting blood sugar; BMI, body mass index; TG, triglyceride; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; Cerebral Inf., cerebral infarction; OHA, oral hypoglycemic agents; SE, standard error.
P-values were determined using the Rao-Scott chi-square test.